Position in NVO
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$41,899
+$9,780 QoQ
Shares Held
874
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#1,132
of 1,348 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ENTRUST FINANCIAL LLC holds $742,641 across 9 Drug Manufacturers - General names. NVO ranks #7 (5.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
1,066 | $268,248 | |
| 2 | JNJ |
Johnson & Johnson
|
541 | $137,397 | |
| 3 | NVS |
Novartis AG
|
418 | $65,508 | |
| 4 | PFE |
Pfizer Inc
|
2,610 | $62,848 | |
| 5 | AZN |
Astrazeneca PLC
|
274 | $51,955 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
870 | $50,129 | |
| 7 | NVO |
Novo Nordisk A S
This page
|
874 | $41,899 | |
| 8 | MRK |
Merck & Co., Inc.
|
320 | $41,120 |
All Filings in NVO
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $41,899 | 874 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $32,119 | 874 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $69,654 | 1,369 | Shares | Sole | 2026-02-06 | |
| No filing history on record for this holder in this stock. | ||||||